Library
PRE-084
PRE-084 is used primarily as a research ligand. Human anecdotal reports describe mild cognitive stimulation, enhanced focus, and subtle mood-lifting properties with little recreational value. Pharmacokinetic work in mice shows rapid CNS penetration and a plasma half-life of approximately 3 hours; human kinetics remain uncharacterised. Off-target activity appears minimal at low doses but increases with higher concentrations.
Also known as: Fenclimorate, Research ligand PRE-084
Classification
- Psychoactive: Nootropic
- Tag: Antidepressant
- Tag: Morpholine derivative
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Mild Mental Stimulation
- Slight Physical Wakefulness
- Insomnia
- Stimulation
- Nausea
- Fatigue
- Enhanced Concentration
- Subtle Mood Elevation
- Potentiation Of Other Psychoactives
- Increased Focus
- Euphoria
- Cognitive Euphoria
- Disinhibition
- Light Sensitivity
- Tactile Suppression
- Hallucinations
- Visual Disconnection
- Double Vision
Routes of Administration
Oral
Dosage
- Threshold: 1-2 mg
- Light: 2-10 mg
- Common: 10-30 mg
- Strong: 30-60 mg
- Heavy: 60+ mg
Duration
- Onset: 0.25-0.75 h
- Peak: 1-2 h
- Offset: 1-2 h
- After Effects: 1-2 h
- Total Duration: 3-5 h
Sublingual
Dosage
- Threshold: 1-2 mg
- Light: 2-10 mg
- Common: 10-30 mg
- Strong: 30-60 mg
- Heavy: 60+ mg
Duration
- Onset: 0.25-0.75 h
- Peak: 1-2 h
- Offset: 1-2 h
- After Effects: 1-2 h
- Total Duration: 3-5 h
Insufflated
Dosage
- Threshold: 1-2 mg
- Light: 2-8 mg
- Common: 8-20 mg
- Strong: 20-40 mg
- Heavy: 40+ mg
Duration
- Onset: 0.08-0.25 h
- Peak: 0.75-1.5 h
- Offset: 1.5-2.5 h
- After Effects: 2.5-4 h
- Total Duration: 3-4 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.